Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Journal of Clinical Pharmacology|April 1, 1988
Fluconazole penetration into cerebrospinal fluid in humansG Foulds, D R Brennan, C Wajszczuk, et al.Therapeutic Drug Monitoring|January 1, 1984
Pharmacokinetics of parenteral sulbactam in patients with appendicitisM A Gill, J W Kern, F C Chenella, et al.Antimicrobial Agents and Chemotherapy|May 1, 1983
Pharmacokinetics of sulbactam in humansG Foulds, J P Stankewich, D C Marshall, et al.The Journal of Antibiotics|April 1, 1990
Pharmacokinetic studies in animals of a new parenteral penem CP-65,207 and its oral prodrug esterT Gootz, D Girard, W Schelkley, et al.Scientific Reports|August 30, 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseasePenelope G Foulds, Peter Diggle, J Douglas Mitchell, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2011
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's diseasePenelope G Foulds, J Douglas Mitchell, Angela Parker, et al.Pharmacotherapy|November 5, 1997
Pharmacokinetics of azithromycin after single- and multiple-doses in childrenR C Stevens, M D Reed, J L Shenep, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|December 31, 1998
Ocular levels of azithromycinK F Tabbara, S A al-Kharashi, S M al-Mansouri, et al.Lancet (London, England)|June 4, 1994
Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparumR A Kuschner, D G Heppner, S L Andersen, et al.Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Magnetite pollution nanoparticles in the human brainBarbara A Maher, Imad A M Ahmed, Vassil Karloukovski, et al.Pageof 7